{"id":279869,"date":"2024-10-19T18:53:48","date_gmt":"2024-10-19T18:53:48","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-11607-22017-tc\/"},"modified":"2024-10-25T15:28:30","modified_gmt":"2024-10-25T15:28:30","slug":"bs-en-iso-11607-22017-tc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-11607-22017-tc\/","title":{"rendered":"BS EN ISO 11607-2:2017 – TC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | compares BS EN ISO 11607-2:2017 <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | TRACKED CHANGES Test example 1 <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | BS EN ISO 11607-2:2017 to BS EN ISO 11607-2:2006 <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 4.1 Quality systems 4.2 Sampling 4.3 Test methods <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 4.4 Documentation 5.1 General <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 5.2 Installation qualification (IQ) <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 5.3 Operational qualification (OQ) 5.4 Performance qualification (PQ) <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 5.5 Formal approval of the process validation 5.6 Process control and monitoring 5.7 Process changes and revalidation <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | Table ZA.1 \u2014 Correspondence between this International Standard and Directive 93\/42\/EEC on medical devices <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | Bibliography <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | Annex\u00a0ZA (informative)Relationship between this European Standard and the essential requirements of Directive 93\/42\/EEC [OJ L 169] aimed to be covered <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Annex\u00a0ZB (informative)Relationship between this European Standard and the essential requirements of Directive 90\/385\/EEC [OJ L 189] aimed to be covered <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | Annex\u00a0ZC (informative)Relationship between this European Standard and the essential requirements of Directive 98\/79\/EC [OJ L 331] aimed to be covered <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | 4 General requirements 4.1 Quality systems 4.2 Sampling 4.3 Test methods <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | 4.4 Documentation 5 Validation of packaging processes 5.1 General <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | 5.2 Installation qualification (IQ) 5.3 Operational qualification (OQ) <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | 5.4 Performance qualification (PQ) <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | 5.5 Formal approval of the process validation 5.6 Process control and monitoring 5.7 Process changes and revalidation 6 Packaging system assembly <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | 7 Use of reusable sterile barrier systems 8 Sterile fluid-path packaging <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | Annex A (informative) Process development <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Packaging for terminally sterilized medical devices – Validation requirements for forming, sealing and assembly processes<\/b><\/p>\n |